Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:29:56 +0200Tue, 02 Jul 2024 13:14:00 +0200Human medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ibranceHuman medicines European public assessment report (EPAR): Ibrance, palbociclib, Date of authorisation: 09/11/2016, Revision: 18, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/ibranceTue, 02 Jul 2024 13:14:00 +0200Human medicineIbrance : EPAR - Summary for the publichttps://www.ema.europa.eu/system/files/documents/overview/h-3853-summary_en.pdfIbrance : EPAR - Summary for the publichttps://www.ema.europa.eu/system/files/documents/overview/h-3853-summary_en.pdfFri, 06 Mar 2020 01:00:00 +0100Human medicine